Apnimed, Inc. APMD
IPO
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -29.40% | 2,608.85% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -29.40% | 2,608.85% | |||
| Cost of Revenue | -29.81% | 64.01% | |||
| Gross Profit | -29.35% | 4,456.45% | |||
| SG&A Expenses | 136.76% | 18.94% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 3.20% | -44.55% | |||
| Operating Income | -97.17% | 350.97% | |||
| Income Before Tax | 2,341.21% | 363.76% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 2,341.21% | 363.76% | |||
| Earnings from Discontinued Operations | 99.72% | -35.06% | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 281.27% | 336.40% | |||
| EBIT | -97.17% | 350.97% | |||
| EBITDA | -97.25% | 351.06% | |||
| EPS Basic | 279.64% | 333.75% | |||
| Normalized Basic EPS | 2,332.94% | 352.98% | |||
| EPS Diluted | 126.80% | 128.59% | |||
| Normalized Diluted EPS | 431.09% | 131.94% | |||
| Average Basic Shares Outstanding | 0.91% | 1.13% | |||
| Average Diluted Shares Outstanding | 580.54% | 701.05% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||